David Dayya, Owen O'Neill, Nusrat Habib, Joanna Moore, Kartik Iyer, Tania B Huedo-Medina
{"title":"糖尿病足溃疡的清创:公共卫生和临床意义--系统回顾、荟萃分析和荟萃回归。","authors":"David Dayya, Owen O'Neill, Nusrat Habib, Joanna Moore, Kartik Iyer, Tania B Huedo-Medina","doi":"10.1136/bmjsit-2021-000081","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Diabetic foot ulceration (DFU) has devastating complications and a lifetime occurrence of 15%-34%. Debridement of DFU is regarded as an intervention that accelerates ulcer healing and may reduce complications including amputations, infections, and poor quality of life (QoL), which have serious public health and clinical implications. A systematic review (SR) of SRs and of randomized controlled trials (RCTs) with meta-analyses (MAs) on debridement of DFU that synthesizes all human experimental evidence is warranted.</p><p><strong>Objectives: </strong>Are debridement methods in DFU beneficial over other forms and standard gauze dressings (control condition) in these outcomes?</p><p><strong>Study eligibility criteria: </strong>All SRs/MAs/RCTs comparing debridement methods for DFU with alternative methods of debridement and with control.</p><p><strong>Data sources: </strong>Cochrane Wounds Group Specialized Register, Cochrane Central Register of Controlled Trials (Cochrane Library), Ovid MEDLINE, PubMed, EMBASE, EBSCO, CINAHL, and Web of Science.</p><p><strong>Participants and interventions: </strong>Adults with type 1/2 diabetes with DFU and any debridement method compared with alternative debridement methods or control.</p><p><strong>Main outcomes: </strong>Amputation rates, wound infections, QoL, proportion of ulcers healed, time to complete healing, ulcer recurrence, and treatment cost.</p><p><strong>Study selection and analysis: </strong>Data extraction/synthesis by two independent reviewers pooled using a random-effects model with sensitivity analysis.</p><p><strong>Results: </strong>10 SRs were retrieved and reported qualitatively. Six SRs included MAs. This SR included 30 studies, with 2654 participants, using 19 debridement combinations. The debridement methods were compared with findings pooled into MAs. Meta-regression (MR) did not identify significant predictors/moderators of outcomes.</p><p><strong>Limitations: </strong>The studies may have been under-powered. The inclusion/exclusion criteria varied and the increased risk of bias contributed to low-quality evidence.</p><p><strong>Discussion/conclusion: </strong>Weak evidence exists that debridement methods are superior to other forms of debridement or control in DFU.</p><p><strong>Implications: </strong>Researchers should follow standardized reporting guidelines (Consolidated Standards of Reporting Trials). Clinicians/investigators could use the findings from this SR/MA/MR in guiding patient-individualized decision making and designing future RCTs.</p>","PeriodicalId":33349,"journal":{"name":"BMJ Surgery Interventions Health Technologies","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2022-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/06/db/bmjsit-2021-000081.PMC9152938.pdf","citationCount":"0","resultStr":"{\"title\":\"Debridement of diabetic foot ulcers: public health and clinical implications - a systematic review, meta-analysis, and meta-regression.\",\"authors\":\"David Dayya, Owen O'Neill, Nusrat Habib, Joanna Moore, Kartik Iyer, Tania B Huedo-Medina\",\"doi\":\"10.1136/bmjsit-2021-000081\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Diabetic foot ulceration (DFU) has devastating complications and a lifetime occurrence of 15%-34%. Debridement of DFU is regarded as an intervention that accelerates ulcer healing and may reduce complications including amputations, infections, and poor quality of life (QoL), which have serious public health and clinical implications. A systematic review (SR) of SRs and of randomized controlled trials (RCTs) with meta-analyses (MAs) on debridement of DFU that synthesizes all human experimental evidence is warranted.</p><p><strong>Objectives: </strong>Are debridement methods in DFU beneficial over other forms and standard gauze dressings (control condition) in these outcomes?</p><p><strong>Study eligibility criteria: </strong>All SRs/MAs/RCTs comparing debridement methods for DFU with alternative methods of debridement and with control.</p><p><strong>Data sources: </strong>Cochrane Wounds Group Specialized Register, Cochrane Central Register of Controlled Trials (Cochrane Library), Ovid MEDLINE, PubMed, EMBASE, EBSCO, CINAHL, and Web of Science.</p><p><strong>Participants and interventions: </strong>Adults with type 1/2 diabetes with DFU and any debridement method compared with alternative debridement methods or control.</p><p><strong>Main outcomes: </strong>Amputation rates, wound infections, QoL, proportion of ulcers healed, time to complete healing, ulcer recurrence, and treatment cost.</p><p><strong>Study selection and analysis: </strong>Data extraction/synthesis by two independent reviewers pooled using a random-effects model with sensitivity analysis.</p><p><strong>Results: </strong>10 SRs were retrieved and reported qualitatively. Six SRs included MAs. This SR included 30 studies, with 2654 participants, using 19 debridement combinations. The debridement methods were compared with findings pooled into MAs. Meta-regression (MR) did not identify significant predictors/moderators of outcomes.</p><p><strong>Limitations: </strong>The studies may have been under-powered. The inclusion/exclusion criteria varied and the increased risk of bias contributed to low-quality evidence.</p><p><strong>Discussion/conclusion: </strong>Weak evidence exists that debridement methods are superior to other forms of debridement or control in DFU.</p><p><strong>Implications: </strong>Researchers should follow standardized reporting guidelines (Consolidated Standards of Reporting Trials). Clinicians/investigators could use the findings from this SR/MA/MR in guiding patient-individualized decision making and designing future RCTs.</p>\",\"PeriodicalId\":33349,\"journal\":{\"name\":\"BMJ Surgery Interventions Health Technologies\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2022-05-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/06/db/bmjsit-2021-000081.PMC9152938.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMJ Surgery Interventions Health Technologies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/bmjsit-2021-000081\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Surgery Interventions Health Technologies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjsit-2021-000081","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
摘要
背景:糖尿病足溃疡(DFU)具有破坏性并发症,终生发病率为 15%-34%。对糖尿病足溃疡进行清创治疗被认为是一种干预措施,可加快溃疡愈合,减少截肢、感染和生活质量低下等并发症,对公共卫生和临床都有严重影响。因此,有必要就 DFU 的清创进行系统综述(SR)和随机对照试验(RCT),并进行荟萃分析(MA),以综合所有人类实验证据:研究资格标准:所有比较 DFU 清创方法与其他清创方法及对照组的 SR/MA/RCT:Cochrane Wounds Group Specialized Register、Cochrane Central Register of Controlled Trials (Cochrane Library)、Ovid MEDLINE、PubMed、EMBASE、EBSCO、CINAHL 和 Web of Science:主要结果:主要结果:截肢率、伤口感染、QoL、溃疡愈合比例、完全愈合时间、溃疡复发和治疗成本:数据提取/综合:由两名独立审稿人使用随机效应模型和敏感性分析进行汇总:结果:共检索到 10 篇 SR,并进行了定性报告。有 6 份研究报告纳入了 MA。本研究纳入了 30 项研究,共有 2654 人参与,使用了 19 种清创组合。对清创方法进行了比较,并将结果汇总到 MAs 中。元回归(Meta-Regression,MR)没有发现显著的结果预测因子/调节因子:局限性:研究可能未达到预期效果。讨论/结论:在 DFU 中,清创方法优于其他清创或控制方法的证据不足:研究人员应遵循标准化报告指南(试验报告综合标准)。临床医生/研究人员可利用该SR/MA/MR的研究结果来指导患者的个体化决策,并设计未来的RCT。
Debridement of diabetic foot ulcers: public health and clinical implications - a systematic review, meta-analysis, and meta-regression.
Background: Diabetic foot ulceration (DFU) has devastating complications and a lifetime occurrence of 15%-34%. Debridement of DFU is regarded as an intervention that accelerates ulcer healing and may reduce complications including amputations, infections, and poor quality of life (QoL), which have serious public health and clinical implications. A systematic review (SR) of SRs and of randomized controlled trials (RCTs) with meta-analyses (MAs) on debridement of DFU that synthesizes all human experimental evidence is warranted.
Objectives: Are debridement methods in DFU beneficial over other forms and standard gauze dressings (control condition) in these outcomes?
Study eligibility criteria: All SRs/MAs/RCTs comparing debridement methods for DFU with alternative methods of debridement and with control.
Data sources: Cochrane Wounds Group Specialized Register, Cochrane Central Register of Controlled Trials (Cochrane Library), Ovid MEDLINE, PubMed, EMBASE, EBSCO, CINAHL, and Web of Science.
Participants and interventions: Adults with type 1/2 diabetes with DFU and any debridement method compared with alternative debridement methods or control.
Main outcomes: Amputation rates, wound infections, QoL, proportion of ulcers healed, time to complete healing, ulcer recurrence, and treatment cost.
Study selection and analysis: Data extraction/synthesis by two independent reviewers pooled using a random-effects model with sensitivity analysis.
Results: 10 SRs were retrieved and reported qualitatively. Six SRs included MAs. This SR included 30 studies, with 2654 participants, using 19 debridement combinations. The debridement methods were compared with findings pooled into MAs. Meta-regression (MR) did not identify significant predictors/moderators of outcomes.
Limitations: The studies may have been under-powered. The inclusion/exclusion criteria varied and the increased risk of bias contributed to low-quality evidence.
Discussion/conclusion: Weak evidence exists that debridement methods are superior to other forms of debridement or control in DFU.
Implications: Researchers should follow standardized reporting guidelines (Consolidated Standards of Reporting Trials). Clinicians/investigators could use the findings from this SR/MA/MR in guiding patient-individualized decision making and designing future RCTs.